Clinical Trial Update: Study of Low Molecular Weight Heparins [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of low molecular weight heparins for anticoagulation indications; no results or status provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anticoagulant Therapy
• Venous Thromboembolism

Drugs mentioned

• Low molecular weight heparins

Snippet

Sponsor: Herlev Hospital | Conditions: Anticoagulant, Venous Thromboembolism | Phase 4 | Status: UNKNOWN